4.4 Article

Leucine and citrulline modulate muscle function in malnourished aged rats

期刊

AMINO ACIDS
卷 42, 期 4, 页码 1425-1433

出版社

SPRINGER WIEN
DOI: 10.1007/s00726-011-0841-2

关键词

Amino acids; Muscle mass; Maximal tetanic isometric force; Motor activity; Ageing

向作者/读者索取更多资源

Protein energy malnutrition in the elderly causes preferential loss of muscle mass which is associated with poor functional states. Leucine and citrulline are able to stimulate muscle protein synthesis in aged rats but no study has been undertaken to evaluate their effect on muscle function. Sprague-Dawley male rats aged 23 months were used in the experiment. Part of them were subjected to a dietary restriction for 12 weeks and then assigned to four groups: a group was euthanized (restricted group), and the others were refed for 1 week with either a leucine-, a citrulline-supplemented diet, or a standard diet. The other rats were fed ad libitum. Muscle mass and motor activity significantly increased during the refeeding with either leucine or citrulline (respectively, +51 and +37% for muscle mass, P < 0.05). The improvement of muscle mass and of motor activity induced by leucine and citrulline was highly associated with that of maximal tetanic isometric force (r = 0.769, P < 0.0001; r = 0.389, P < 0.05, respectively) but only leucine improved maximal tetanic isometric force (+101%, P < 0.05). In conclusion, this is the first study to demonstrate the ability of two amino acids (leucine and citrulline) to modulate muscle function.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, Research & Experimental

Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient- derived cells and mice

Arnaud F. Klein, Miguel A. Varela, Ludovic Arandel, Ashling Holland, Naira Naouar, Andrey Arzumanov, David Seoane, Lucile Revillod, Guillaume Bassez, Arnaud Ferry, Dominic Jauvin, Genevieve Gourdon, Jack Puymirat, Michael J. Gait, Denis Furling, Matthew J. A. Wood

JOURNAL OF CLINICAL INVESTIGATION (2019)

Meeting Abstract Clinical Neurology

A novel CaVβ1 isoform connecting voltage sensing with muscle mass homeostasis

M. Traore, C. Gentil, C. Benedetto, J. -Y. Hogrel, P. De la Grange, S. Benkhelifa-Ziyyat, L. Julien, M. Lemaitre, A. Ferry, S. Falcone

NEUROMUSCULAR DISORDERS (2019)

Article Cell Biology

An embryonic CaVβ1 isoform promotes muscle mass maintenance via GDF5 signaling in adult mouse

Massire Traore, Christel Gentil, Chiara Benedetto, Jean-Yves Hogrel, Pierre De la Grange, Bruno Cadot, Sofia Benkhelifa-Ziyyat, Laura Julien, Megane Lemaitre, Arnaud Ferry, France Pietri-Rouxel, Sestina Falcone

SCIENCE TRANSLATIONAL MEDICINE (2019)

Article Neurosciences

Desmin prevents muscle wasting, exaggerated weakness and fragility, and fatigue in dystrophic mdx mouse

Arnaud Ferry, Julien Messeant, Ara Parlakian, Megane Lemaitre, Pauline Roy, Clement Delacroix, Alain Lilienbaum, Yeranuhi Hovhannisyan, Denis Furling, Arnaud Klein, Zhenlin Li, Onnik Agbulut

JOURNAL OF PHYSIOLOGY-LONDON (2020)

Article Cell Biology

Differential physiological roles for BIN1 isoforms in skeletal muscle development, function and regeneration

Ivana Prokic, Belinda S. Cowling, Candice Kutchukian, Christine Kretz, Hichen Tasfaout, Vincent Gache, Josiane Hergueux, Olivia Wendling, Arnaud Ferry, Anne Toussaint, Christos Gavriilidis, Vasugi Nattarayan, Catherine Koch, Jeanne Laine, Roy Combe, Laurent Tirent, Vincent Jacquemond, Fanny Pilot-Storck, Jocelyn Laporte

DISEASE MODELS & MECHANISMS (2020)

Article Biochemistry & Molecular Biology

Lamin-Related Congenital Muscular Dystrophy Alters Mechanical Signaling and Skeletal Muscle Growth

Daniel J. Owens, Julien Messeant, Sophie Moog, Mark Viggars, Arnaud Ferry, Kamel Mamchaoui, Emmanuelle Lacene, Norma Romero, Astrid Brull, Gisele Bonne, Gillian Butler-Browne, Catherine Coirault

Summary: Laminopathies are a group of disorders caused by mutations in the LMNA gene, particularly affecting skeletal and cardiac muscles. Mutations in LMNA-CMD lead to impaired myogenic fusion, defective protein synthesis, and neuromuscular junction remodeling. This study suggests that A-type lamins play a role in mechanosignaling pathways in skeletal muscle growth.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Myod1 and GR coordinate myofiber-specific transcriptional enhancers

Daniela Rovito, Anna-Isavella Rerra, Vanessa Ueberschlag-Pitiot, Shilpy Joshi, Nezih Karasu, Vanessa Dacleu-Siewe, Khalil Ben Rayana, Kamar Ghaibour, Maxime Parisotto, Arnaud Ferry, Scott A. Jelinsky, Gilles Laverny, Bruno P. Klaholz, Tom Sexton, Isabelle M. L. Billas, Delphine Duteil, Daniel Metzger

Summary: Skeletal muscle size can be remodeled through various cues, with Myod1, GR, and Nrf1 identified as key players in muscle-specific enhancer-promoter communication. The study reveals that these factors control gene expression through direct contacts, transcription factor Nrf1 regulation, and Ctcf-anchored chromatin loops, orchestrating myofiber size regulation in a myofiber-specific manner. Additionally, GR negatively regulates muscle mass and strength in mice by down-regulating anabolic pathways.

NUCLEIC ACIDS RESEARCH (2021)

Article Cell Biology

Absence of Desmin Results in Impaired Adaptive Response to Mechanical Overloading of Skeletal Muscle

Pierre Joanne, Yeranuhi Hovhannisyan, Maximilien Bencze, Marie-Therese Daher, Ara Parlakian, Geraldine Toutirais, Jacqueline Gao-Li, Alain Lilienbaum, Zhenlin Li, Ekaterini Kordeli, Arnaud Ferry, Onnik Agbulut

Summary: Desmin plays a crucial role in muscle remodeling and performance gain induced by mechanical overloading, impacting fatigue resistance and myofibril organization. The lack of desmin affects the functional response to overloading, leading to compromised repair activity of autophagy and altered proteolysis pathways.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Engineering, Biomedical

Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats

Ludovic Arandel, Magdalena Matloka, Arnaud F. Klein, Frederique Rau, Alain Sureau, Michel Ney, Aurelien Cordier, Maria Kondili, Micaela Polay-Espinoza, Naira Naouar, Arnaud Ferry, Megane Lemaitre, Severine Begard, Morvane Colin, Chloe Lamarre, Helene Tran, Luc Buee, Joelle Marie, Nicolas Sergeant, Denis Furling

Summary: Decoy RNA-binding proteins effectively reverse the toxicity of mutant CUG RNA repeats in myotonic dystrophy, restoring normal RNA splicing and improving disease pathology in cell and mouse models.

NATURE BIOMEDICAL ENGINEERING (2022)

Article Medicine, General & Internal

Alteration of skeletal and cardiac muscles function in DBA/2J mdx mice background: a focus on high intensity interval training

Narjes Baati, Nathalie Mougenot, Megane Lemaitre, Marine Kirsch, Onnik Agbulut, Arnaud Ferry, Damien Vitiello

Summary: Duchenne muscular dystrophy (DMD) is a recessive hereditary myopathy caused by deficiency of functional dystrophin. Current therapeutic interventions need further research to slow down muscle weakness. In this study, male and female D2-mdx mice showed significant muscle function alterations compared to control groups, and high intensity interval training (HIIT) may delay muscle force loss especially in male D2-mdx mice.

INTRACTABLE & RARE DISEASES RESEARCH (2021)

Article Multidisciplinary Sciences

The beneficial effect of chronic muscular exercise on muscle fragility is increased by Prox1 gene transfer in dystrophic mdx muscle

Alexandra Monceau, Clement Delacroix, Megane Lemaitre, Gaelle Revet, Denis Furling, Onnik Agbulut, Arnaud Klein, Arnaud Ferry

Summary: Prox1 transfer reduced muscle fragility in exercised mdx mice but not in sedentary mice. Additionally, it increased the expression of specific muscle proteins while decreasing others.

PLOS ONE (2022)

Article Biochemistry & Molecular Biology

The cell polarity protein Vangl2 in the muscle shapes the neuromuscular synapse by binding to and regulating the tyrosine kinase MuSK

Myriam Boex, Steve Cottin, Marius Halliez, Stephanie Bauche, Celine Buon, Nathalie Sans, Mireille Montcouquiol, Jordi Molgo, Muriel Amar, Arnaud Ferry, Megane Lemaitre, Andree Rouche, Dominique Langui, Asha Baskaran, Bertrand Fontaine, Julien Messeant, Laure Strochlic

Summary: Investigating the function of Vangl2 protein in the Wnt signaling pathway, a study found that it plays a crucial role in the development and assembly of neuromuscular junctions (NMJs). Loss of Vangl2 protein leads to disorganized distribution of acetylcholine receptors (AChRs) in NMJs, resulting in impaired neurotransmission and motor function.

SCIENCE SIGNALING (2022)

Article Pathology

Dystrophin Restoration after Adeno-Associated Virus U7-Mediated Dmd Exon Skipping Is Modulated by Muscular Exercise in the Severe D2-Mdx Duchenne Muscular Dystrophy Murine Model

Alexandra Monceau, Dylan Moutachi, Megane Lemaitre, Luis Garcia, Capucine Trollet, Denis Furling, Arnaud Klein, Arnaud Ferry

Summary: This study evaluated the impact of voluntary exercise on gene therapy exon skipping approach in a severe DMD murine model. The results showed that voluntary running did not induce muscle damage and did not have a drastic detrimental effect on the gene therapy method. Moreover, these findings suggest considering exercise as an additional factor in future therapeutic approaches for DMD.

AMERICAN JOURNAL OF PATHOLOGY (2022)

Article Pharmacology & Pharmacy

Valproic acid reduces muscle susceptibility to contraction-induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy

Dylan Moutachi, Megane Lemaitre, Clement Delacroix, Onnik Agbulut, Denis Furling, Arnaud Ferry

Summary: Valproic acid (VPA) reduces susceptibility to contraction-induced functional loss but increases muscle weakness in murine models of DMD.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2023)

Meeting Abstract Biotechnology & Applied Microbiology

Decoy-based gene therapy for Myotonic Dystrophy

M. Matloka, L. Arandel, F. Rau, J. Marie, M. Ney, A. Klein, A. Sureau, N. Naouar, A. Ferry, N. Sergeant, D. Furling

HUMAN GENE THERAPY (2019)

暂无数据